SurModics to Present at Oppenheimer Healthcare Conference
Webcast is Live on Tuesday, December 8, at 10:55 a.m. (ET)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Dec. 1, 2015--
SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in
vitro diagnostic technologies, today announced that Gary Maharaj,
president and chief executive officer, and Andy LaFrence, vice president
of finance and chief financial officer, will make a presentation to the
investment community at the Oppenheimer Healthcare Conference in New
York City on Tuesday, December 8, 2015, at 10:55 a.m. ET (9:55 a.m. CT).
A live audio webcast of the presentation, with accompanying slides, will
be available by going to the investor relations portion of the Company’s
website at www.surmodics.com
and clicking on the webcast icon. The webcast will be archived on the
Company’s website and will be available through March 7, 2016.
About SurModics, Inc.
SurModics partners with the world's leading and emerging medical device,
diagnostic and life sciences companies to develop and commercialize
innovative products designed to improve lives by enabling the detection
and treatment of disease. The company’s core offerings include surface
modification coating technologies that impart lubricity, prohealing and
biocompatibility characteristics and components for in vitro diagnostic
test kits and microarrays. SurModics’ strategy is to build on the
product and technical leadership within these fields, and expand the
core offerings to generate opportunities for longer term sustained
growth. SurModics is headquartered in Eden Prairie, Minnesota. For more
information about the company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151201005610/en/
Source: SurModics, Inc.
Andy LaFrence, 952-500-7000